None listed
Conditions
Interventions
Drug : At one hour before the end of the surgery , Nefopam group receives nefopam 20 mg diluted in 20 ml normal saline and The control group receives 20 ml of normal saline for 20 minutes.
Sponsors
Korea University Ansan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with spinal stenosis due to radicular or enurogenic claudication and scheduled to undergo spinal surgery (decompressionsurgery with or without fusion) 2) Adult patients aged 20-75 3) American Society of Anesthesiology Physical Classification 1,2 patients 4) Patients with informed consent
Exclusion criteria
Exclusion criteria: ) Patient with lumbar disc herniation or other spinal disorders 2)Patient with polyneuropathy, or arteriosclerosis obliterans 3)Patient with severe pain or disability in other joints 4)Patient with a psychiatric illness 5) Patient with peripheral vascular disease 6) Patient with a serious disease that may affect systemic condition, including cancer or cardiopulmonary disease 7) Patients sensitive to study drug 8) Patients with epilepsy or convulsions. 9) Patients taking irreversible monoamine oxidase inhibitors 8) Patients with a history of myocardial infarction 9) Patients with angle-closure glaucoma 10) Patients with urinary retention or urethral and prostate disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| severity of paresthesia or abnormal sensation (Visual Analogue Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| severity of back pain (Visual Analogue Scale) | — |
Countries
Korea, Republic of
Contacts
Public ContactEunsu Choi
Korea University Ansan Hospital
Outcome results
None listed